Sparrow Pharma Enrolls First Patient In Phase 2B Trial
06 Jan 2026 //
GLOBENEWSWIRE
Sparrow Pharma Secures $95m Series B For Type 2 Diabetes Therapy
24 Sep 2025 //
GLOBENEWSWIRE
Sparrow Collab with Oxford & Sheffield on Ph 2 Clofutriben Study
11 Dec 2024 //
BUSINESSWIRE

Market Place
Sourcing Support